0 CHECKOUT

PRODUCT FILTERS

REGION

51
3
1
1
1

COUNTRY

1

CATEGORIES

  • 17
  • 11
  • 10
  • 9
  • 8
  • 8
  • 8
  • 6
  • 6
  • 5
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

10
18
29
85

PUBLISHED

5
7
15
85

PRODUCT TYPE

65
16
3
1

Search for: "European Markets for Parkinson's Disease Therapeutics"

European Markets for Parkinson's Disease Therapeutics

This research service discusses the market for Parkinson's disease It analyses the various opportunities, recent developments, drug classes and gives a revenue forecasts...

Published:  May 2009
Price:  From

Parkinson’s Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments

Parkinson's Disease (PD) is a progressive, chronic neurodegenerative condition, which is currently incurable. It is associated with old age, and characterized by the loss of neurons in the substantia...

Published:  February 2016
Price:  From

Global Parkinson’s Disease Market Report: 2016 Edition

Parkinson’s Disease (PD) is a chronic and progressive neurodegenerative or movement disorder which involves the malfunction and death of vital nerve cells in the brain, called neurons. Parkinson’s primarily...

Published:  May 2016
Price:  From

Parkinson's Disease Therapeutics Market to 2019 - Pipeline Shows Shift Towards Long Term Disease Management

The Parkinson’s Disease (PD) market is dominated by symptomatic treatments targeting functional impairment in PD Levodopa has remained the gold standard treatment for almost 40 years and has significantly...

Published:  December 2013
Price:  From

Parkinson's Disease Global Clinical Trials Review, H2, 2011

Parkinson’s Disease Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, “Parkinson’s Disease Global Clinical Trials Review, H2, 2011" provides data on the Parkinson’s...

Published:  October 2011
Price:  From

Neurotech Industry 2015-2016 Report: Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System

Now in its 11th year, The Neurotechnology Industry 2015-2016 Report is an expanded and updated 650 page report of brain and nervous system markets and treatments. It is the only publication to provide...

Published:  September 2015
Price:  From

CNS Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups: Anti-Alzheimer's, Anti-Parkinson's, Anti-Epilepsy, Pain Management, Anti-Psychotics, Anti-Depressants,...

Published:  February 2015
Price:  From

Neurostimulation Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Scenario And Forecasts, 2012 To 2020

Industry Insights Growing geriatric population base and rising incidences of target diseases such as Alzheimer’s and Parkinson’s are the major drivers for this market. As per an estimate by the Alzheimer...

Published:  January 2014
Price:  From

Alzheimers and Parkinsons Disease - Global Strategic Business Report

This report analyzes the worldwide markets for Alzheimer’s and Parkinson’s Disease in Millions of US$. The Major product segments Analyzed are Anti-Alzheimer’s Disease Drugs (Cholinesterase Inhibitors,...

Published:  May 2008
Price:  From

The Neurotechnology Industry 2014 Report

Now in its 10th year, The Neurotechnology Industry 2014 Report is an expanded and updated 650 page report of brain and nervous system markets and treatments It is the only publication to provide a comprehensive...

Published:  July 2014
Price:  From

Deep Brain Stimulation Devices - Global Strategic Business Report

This report analyzes the worldwide markets for Deep Brain Stimulation Devices in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin...

Published:  June 2015
Price:  From

Melanoma Therapeutics Market to 2020

Summary: This report is a highly heterogeneous disease comprising Cutaneous Melanoma (CM), Ocular Melanoma (OM), Mucosal Melanoma (MM), melanoma of the internal organs, and, according to some classifications,...

Published:  September 2014
Price:  From

Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer’s, Diabetes, Arthritis and Other Diseases)

There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies....

Published:  January 2012
Price:  From

Neurostimulation Devices Market Analysis by Product, by Application and Segment Forecasts to 2020

Neurostimulation Devices Market Analysis By Product (Deep Brain, Gastric Electric, Gastric Electric, Spinal Cord, Sacral Nerve And Vagus Nerve Stimulation Device), By Application (Pain Management, Epilepsy,...

Published:  January 2014
Price:  From

Global Neurodegenerative Diseases Market 2015-2019

About neurodegenerative diseases According to the EU JPND, neurodegenerative diseases refer to conditions that involve the neurons in the brain. These conditions can affect balance, movement, speech,...

Published:  May 2015
Price:  From

Stem Cell Therapeutics Markets (Cardiovascular and Circulatory Diseases, Endocrine Diseases, Digestive Disorders, Musculoskeletal, Nervous System, Cancer, Others)

Stem cells are anticipated to demonstrate considerable efficacy in clinical treatment and revenues to manufacturers with suitable products.  Kalorama Information’s Stem Cell Therapeutics Markets is...

Published:  October 2014
Price:  From

Global Transdermal Drug Delivery Market to 2020: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and Swot Investigation

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 320 tables...

Published:  February 2015
Price:  From

Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas

The service oriented and dynamic nature of the healthcare industry has led to the discovery of a plethora of treatment options for a wide range of ailments.However, there are certain diseases, termed...

Published:  March 2015
Price:  From

The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007

With a market size of US$14 5 billion in 2005 and an anticipated value of US$16 5 billion in 2006, the neurodegenerative market represents a valuable, fast-growing opportunity in the pharma/biotech...

Published:  January 2007
Price:  From

The Neurodevice 2013 Report: Neuroprosthetics, Neuromodulation, Neurosurgery, Neurovascular Intervention and Neurosoftware.

An Industry Insider Report Covering Therapeutic Neurodevices including Neuroprosthetics, Neuromodulation, Neurovascular Interventions, Neurosurgical Devices and Neurosoftware Nearly 2 billion people...

Published:  August 2013
Price:  From
Loading Indicator

Our Clients

  • Carrefour S.A.
  • Dow Chemical Co Ltd.
  • Motorola Solutions, Inc.
  • Activision Publishing, Inc.
  • 3M Company
  • Estée Lauder Companies Inc.